Taiwan News3d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...
Let’s stop worrying about the Blueprint and start worrying about outcomes
Defenders of the Blueprint for Maryland's Future, the state's sweeping education reform plan, are fixated on saving the plan ...